Log in or Sign up for Free to view tailored content for your specialty!
Alzheimer’s Disease/Dementia News
Study finds no link between late-life depression, global amyloid deposition
ORLANDO, Fla. — Among a cohort of patients within the Atherosclerosis Risk in Communities study, no link was found between late-life depression and global amyloid deposition, according to a poster at the American Neurological Association.
FDA grants 510(k) clearance to amyloid imaging tool
The FDA has granted 510(k) clearance to a Centiloid scaling apparatus software for positron emission tomography-based amyloid imaging to evaluate individuals for Alzheimer’s disease-related pathology.
Depressive symptoms linked to amyloid accumulation, suggesting ties to preclinical AD
Increasing depressive symptoms among cognitively unimpaired older adults appeared significantly associated with early amyloid accumulation in brain regions involved in emotional control, according to a study published in JAMA Network Open.
Log in or Sign up for Free to view tailored content for your specialty!
Trauma, sexual assault exposure may be ‘toxic’ for women’s brain health
CHICAGO — Exposure to trauma was tied to increased measures of inflammation and neuronal death for Black women and accelerated brain age indicators regardless of race and ethnicity, researchers reported.
Diabetes drug linked to reduced risk for several types of dementia
Type 2 diabetes has emerged as a possible risk factor contributing to the development of dementia, but one class of agents used to treat the disease may provide greater protective effects, study results published in BMJ showed.
NSAIDs, Part 3: The rise, fall and rise again of COX-2 inhibition
In the third episode of the NSAIDs saga, we focus on COX-2 inhibition! Did the hopes and dreams of selective COX-2 inhibition pan out? What can the rise and fall of VIOXX teach us about physiology?
Microstimulation models may help predict population-level dementia burden
PHILADELPHIA — The creation of microstimulation models may help predict population-level dementia burdens by the year 2050; however, the success of the model is dependent on the size and quality of the data, according to a presenter.
SGLT2 inhibitors tied to similar dementia risk as dulaglutide in type 2 diabetes
SGLT2 inhibitors and dulaglutide confer a similar risk for dementia among adults aged 60 years and older with type 2 diabetes, according to findings published in Annals of Internal Medicine.
Any level of physical activity linked to improved brain health
Individuals who engaged in some form of exercise or physical activity on a regular or semi-regular basis demonstrated better brain health compared with inactive individuals, according to research from Nature Aging.
‘Concerning trends’ in dementia mortality most notable among Black adults, women in US
Mortality data from 1999 to 2020 revealed an upward trend in dementia-related mortality in the United States, especially among Black adults and women, according to a study published in The Primary Care Companion for CNS Disorders.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read